Apolipoprotein B: An essential cholesterol metric for atherosclerotic cardiovascular disease

被引：1

作者：

Fischer, Kyle ^{[1
]}

Kassem, Layla ^{[2
]}

机构：

[1] Duke Univ Hosp, Durham, NC 27710 USA

[2] Univ Texas Tyler, Ben & Maytee Fisch Coll Pharm, Tyler, TX USA

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2023年 / 80卷 / 02期

关键词：

apoB; apolipoproteins; ASCVD; cardiovascular disease; dyslipidemia; DENSITY-LIPOPROTEIN CHOLESTEROL; LDL-CHOLESTEROL; RISK; ASSOCIATION; DISCORDANCE; MANAGEMENT; STATEMENT; MARKERS; PLASMA; LIPIDS;

D O I：

10.1093/ajhp/zxac287

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：83 / 86

页数：4

共 27 条

[1] Arnett DK, 2019, CIRCULATION, V140, pE563, DOI [10.1161/CIR.0000000000000677, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]
[2] AVOGARO P, 1979, LANCET, V1, P901
[3] Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B -: The Copenhagen city heart study
Benn, Marianne
Nordestgaard, Borge G.
Jensen, Gorm Boje
Tybjærg-Hansen, Anne
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (03) : 661 - 670
[4] The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity
Boren, Jan
Williams, Kevin Jon
[J]. CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (05) : 473 - 483
[5] Relationship of apolipoprotein B levels to the number of risk factors for metabolic syndrome
Clarenbach, Jacob J.
Grundy, Scott M.
Palacio, Natalia
Vega, Gloria Lena
[J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (05) : 237 - 247
[6] Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619
[7] RAPID ISOLATION OF LOW-DENSITY-LIPOPROTEIN (LDL) SUBFRACTIONS FROM PLASMA BY DENSITY GRADIENT ULTRACENTRIFUGATION
GRIFFIN, BA
CASLAKE, MJ
YIP, B
TAIT, GW
PACKARD, CJ
SHEPHERD, J
[J]. ATHEROSCLEROSIS, 1990, 83 (01) : 59 - 67
[8] Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI [10.1016/j.jacc.2018.11.002, 10.1016/j.jacc.2018.11.003, 10.1161/CIR.0000000000000625]
[9] CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE ALGORITHM-2020 EXECUTIVE SUMMARY
Handelsman, Yehuda
Jellinger, Paul S.
Guerin, Chris K.
Bloomgarden, Zachary T.
Brinton, Eliot A.
Budoff, Matthew J.
Davidson, Michael H.
Einhorn, Daniel
Fazio, Sergio
Fonseca, Vivian A.
Garber, Alan J.
Grunberger, George
Krauss, Ronald M.
Mechanick, Jeffrey, I
Rosenblit, Paul D.
Smith, Donald A.
Wyne, Kathleen L.
[J]. ENDOCRINE PRACTICE, 2020, 26 (10) : 1196 - 1224
[10] Using Apolipoprotein B to Manage Dyslipidemic Patients: Time for a Change?
Harper, Charles R.
Jacobson, Terry A.
[J]. MAYO CLINIC PROCEEDINGS, 2010, 85 (05) : 440 - 445

← 1 2 3 →